Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

British Business Bank writes £180m into six AI funds

3 min read
16:30UTC

The Bank committed £180m on 15 October to six AI and deep-tech venture funds, three of them with mandates that run wider than Britain.

TechnologyAssessed
Key takeaway

The Bank's £180m of AI fund commitments sets no requirement to back British companies.

The British Business Bank committed £180m on 15 October across six artificial intelligence (AI) and deep-tech venture funds that between them have raised more than £1bn⁠1. Intrepid Growth Partners took the largest cheque, £55m into a $525m debut fund. Crane Venture Partners got £35m, Headline £26m into its $400m EU VIII fund, Entrepreneur First and Evantic £22m each, and Connect Ventures £20m. Business Secretary Jonathan Reynolds framed it as "AI makers, not AI takers."

The release sets no condition that the money reach British companies. Three of the six mandates run wider than Britain: Crane backs founders "globally", Headline EU VIII invests "across Europe" and Evantic calls its fund globally focused. Evantic's Matt Miller says The Firm has invested or committed more than £150m in UK businesses; the Bank set no such term. On 12 October, Headline led and Entrepreneur First followed in a $50m Series B for Scarlet, a London company that certifies AI medical devices and is spending the money on hubs in the US and Asia-Pacific⁠2.

The Bank's mandate is to draw private money in behind its own, so it rarely leads. Its direct investments include Wayve, Kraken Technologies, PhysicsX, backed through the British Growth Partnership in July, and Salience Labs.

Its other October commitments came to £15m: two-thirds to Fuel Ventures, with £3m to TSP Ventures and £2m to Cambridge Capital Group through its Regional Angels Programme on the Haatch platform.

Deep Analysis

In plain English

The British Business Bank is a government-owned investor. It does not usually pick companies itself. Instead it puts money into venture capital funds, which are pools of money run by private firms that buy stakes in young companies. This month it put £180m into six such funds that focus on artificial intelligence and advanced technology. The aim is to help British technology companies grow. The announcement does not say the funds must spend the money on British companies. Some of the funds invest across Europe or worldwide.

Deep Analysis
Root Causes

The Bank's core model is fund-of-funds investing: it backs private managers, which pick companies, so that public money draws private money in alongside it. That model gives the Bank no direct say over individual deals once a fund closes.

AI funds also compete for limited partners globally. Managers with European or global mandates, such as Headline and Crane, are less willing to accept national quotas, so a state investor that wants access to them trades conditions for entry.

What could happen next?
  • Risk

    Without published deployment terms, part of the £180m could back companies outside Britain through the Europe-wide and global funds.

  • Opportunity

    British AI founders gain access to managers such as Headline and Intrepid that now have a British state limited partner.

First Reported In

Update #16 · Stryker agrees option to buy CMR Surgical

British Business Bank· 22 Oct 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.